# Abcam (Us) (Abcam (Us) Ltd) Private limited company registered in Cambridge, classed under “Activities of other holding companies n.e.c.”. - Company number: 08151375 - Status: Active - Type: Private limited company - Incorporated: 20 July 2012 - Registered office: Discovery Drive, Cambridge Biomedical Campus, Cambridge, CB2 0AX - Location: Cambridge - Activity: Activities of other holding companies n.e.c. ## Latest filed profit No profit figure in its latest filed accounts. Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers. ## Questions people ask ### What does Abcam (Us) do? Private limited company registered in Cambridge, classed under “Activities of other holding companies n.e.c.”. ### How much turnover does Abcam (Us) make? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/abcam-us-08151375 ### Is Abcam (Us) profitable? Abcam (Us)'s profit isn't public: small companies may file without a profit and loss account. ### Who runs and owns Abcam (Us)? Its directors are Jonathan Peter Fogg, Gillian Claire Louisa Johnson. Its owners are shown to subscribers. ### Where is Abcam (Us) based? Its registered office is Discovery Drive, Cambridge Biomedical Campus, Cambridge, CB2 0AX, in Cambridge. ### When was Abcam (Us) founded? Abcam (Us) Ltd was incorporated on 20 July 2012. ### Is Abcam (Us) still trading? The register lists Abcam (Us) Ltd as active. ## Timeline Recent filings and changes at Companies House. - 2026-08-19: Full accounts made up to 31 December 2025 - 2025-11-12: Notification of Danaher Corporation as a person with significant control on 22 May 2024 - 2025-11-12: Cessation of Abcam Us Group Holdings Inc as a person with significant control on 22 May 2024 - 2025-11-11: Termination of appointment of Nicola Ann Summers as a director on 31 October 2025 - 2025-11-11: Appointment of Jonathan Peter Fogg as a director on 31 October 2025 - 2025-07-30: Full accounts made up to 31 December 2024 - 2024-12-27: Full accounts made up to 31 December 2023 - 2024-12-10: Appointment of Ms Nicola Ann Summers as a director on 29 November 2024 - 2024-12-10: Appointment of Dr Gillian Claire Louisa Johnson as a director on 29 November 2024 - 2024-12-10: Termination of appointment of Emma Sceats as a director on 29 November 2024 - 2024-12-10: Termination of appointment of Jonathan Richard Fearn as a director on 29 November 2024 - 2023-12-15: Statement of capital following an allotment of shares on 27 March 2023 · GBP 143,663,732 (and 2 more like it since 22 August 2017) - 2023-10-09: Audit exemption subsidiary accounts made up to 31 December 2022 - 2023-10-09: Consolidated accounts of parent company for subsidiary company period ending 31/12/22 - 2023-10-09: Notice of agreement to exemption from audit of accounts for period ending 31/12/22 - 2023-10-09: Audit exemption statement of guarantee by parent company for period ending 31/12/22 (and 5 more like it since 21 December 2017) - 2023-09-06: Appointment of Emma Sceats as a director on 29 August 2023 - 2023-07-18: Termination of appointment of John Mark Dudley as a director on 30 June 2023 - 2022-10-06: Audit exemption subsidiary accounts made up to 31 December 2021 - 2022-10-06: Consolidated accounts of parent company for subsidiary company period ending 31/12/21 - 2022-10-06: Notice of agreement to exemption from audit of accounts for period ending 31/12/21 - 2021-06-25: Current accounting period extended from 30 June 2021 to 31 December 2021 - 2021-05-28: Termination of appointment of Dominic Martin Etienne Page as a director on 21 May 2021 - 2021-05-28: Appointment of Mr Jonathan Richard Fearn as a director on 21 May 2021 - 2021-04-07: Audit exemption subsidiary accounts made up to 30 June 2020 --- Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/abcam-us-08151375